Glucose-regulated protein 78 substrate-binding domain alters its conformation upon EGCG inhibitor binding to nucleotide-binding domain: Molecular dynamics studies
- PMID: 29615633
- PMCID: PMC5882873
- DOI: 10.1038/s41598-018-22905-6
Glucose-regulated protein 78 substrate-binding domain alters its conformation upon EGCG inhibitor binding to nucleotide-binding domain: Molecular dynamics studies
Abstract
Glucose-regulated protein 78 (GRP78), is overexpressed in glioblastoma, other tumors and during viral and bacterial infections, and so, it is postulated to be a key drug target. EGCG, an ATP-competitive natural inhibitor, inhibits GRP78 effect in glioblastoma. Structural basis of its action on GRP78 nucleotide-binding domain and selectivity has been investigated. We were interested in exploring the large-scale conformational movements travelling to substrate-binding domain via linker region. Conformational effects of EGCG inhibitor as well as ATP on full length GRP78 protein were studied using powerful MD simulations. Binding of EGCG decreases mobility of residues in SBDα lid region as compared to ATP-bound state and similar to apo state. The decreased mobility may prevent its opening and closing over SBDβ. This hindrance to SBDα subdomain movement, in turn, may reduce the binding of substrate peptide to SBDβ. EGCG binding folds the protein stably as opposed to ATP binding. Several results from EGCG binding simulations are similar to that of the apo state. Key insights from these results reveal that after EGCG binding upon competitive inhibition with ATP, GRP78 conformation may revert to that of inactive, apo state. Further, SBD may adopt a semi-open conformation unable to facilitate association of substrates.
Conflict of interest statement
The authors declare no competing interests.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5882873/bin/41598_2018_22905_Fig1_HTML.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5882873/bin/41598_2018_22905_Fig2_HTML.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5882873/bin/41598_2018_22905_Fig3_HTML.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5882873/bin/41598_2018_22905_Fig4_HTML.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5882873/bin/41598_2018_22905_Fig5_HTML.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5882873/bin/41598_2018_22905_Fig6_HTML.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5882873/bin/41598_2018_22905_Fig7_HTML.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5882873/bin/41598_2018_22905_Fig8_HTML.gif)
![Figure 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5882873/bin/41598_2018_22905_Fig9_HTML.gif)
![Figure 10](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5882873/bin/41598_2018_22905_Fig10_HTML.gif)
Similar articles
-
Stabilization of apo α-lactalbumin by binding of epigallocatechin-3-gallate: Experimental and molecular dynamics study.Food Chem. 2019 Apr 25;278:388-395. doi: 10.1016/j.foodchem.2018.11.038. Epub 2018 Nov 13. Food Chem. 2019. PMID: 30583389
-
In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3-O-gallate (EGCG) with Proteins That Explain the Health Benefits of Green Tea.Molecules. 2018 May 28;23(6):1295. doi: 10.3390/molecules23061295. Molecules. 2018. PMID: 29843451 Free PMC article. Review.
-
Molecular docking and molecular dynamics studies reveal structural basis of inhibition and selectivity of inhibitors EGCG and OSU-03012 toward glucose regulated protein-78 (GRP78) overexpressed in glioblastoma.J Mol Model. 2015 Oct;21(10):272. doi: 10.1007/s00894-015-2801-3. Epub 2015 Sep 29. J Mol Model. 2015. PMID: 26419972
-
Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78.J Mol Model. 2011 May;17(5):987-95. doi: 10.1007/s00894-010-0794-5. Epub 2010 Jul 14. J Mol Model. 2011. PMID: 20628775
-
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.Cancer Res. 2006 Sep 15;66(18):9260-9. doi: 10.1158/0008-5472.CAN-06-1586. Cancer Res. 2006. PMID: 16982771
Cited by
-
Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface.J Comput Aided Mol Des. 2024 Jan 24;38(1):6. doi: 10.1007/s10822-023-00546-w. J Comput Aided Mol Des. 2024. PMID: 38263499
-
α-Mangostin Promotes In Vitro and In Vivo Degradation of Androgen Receptor and AR-V7 Splice Variant in Prostate Cancer Cells.Cancers (Basel). 2023 Apr 1;15(7):2118. doi: 10.3390/cancers15072118. Cancers (Basel). 2023. PMID: 37046780 Free PMC article.
-
Chimeric efferocytic receptors improve apoptotic cell clearance and alleviate inflammation.Cell. 2022 Dec 22;185(26):4887-4903.e17. doi: 10.1016/j.cell.2022.11.029. Cell. 2022. PMID: 36563662 Free PMC article.
-
GRP78 Activity Moderation as a Therapeutic Treatment against Obesity.Int J Environ Res Public Health. 2022 Nov 30;19(23):15965. doi: 10.3390/ijerph192315965. Int J Environ Res Public Health. 2022. PMID: 36498048 Free PMC article. Review.
-
Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective.Comput Biol Med. 2022 Jun;145:105478. doi: 10.1016/j.compbiomed.2022.105478. Epub 2022 Apr 7. Comput Biol Med. 2022. PMID: 35421790 Free PMC article.
References
-
- Ellor, S. V., Pagano-Young, T. A. & Averopoulos, N. G. Glioblastoma: Background, Standard Treatment Paradigms, and Supportive Care Considerations. J. Law, Medicine and Ethics 171–182 (2014). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous